Evidence map›Paper›PMID 11044365›Full record

ArticleBritish journal of cancer2000

Bcl-2/Bax protein ratio predicts 5-fluorouracil sensitivity independently of p53 status.

J F Mirjolet, M Barberi-Heyob, C Didelot, J P Peyrat, J Abecassis, R Millon, J L Merlin

Open access · hybridAbstract read
In one paragraph

Article in British journal of cancer, 2000. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
1.9field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 83 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Roles and Regulation of BCL-xL in Hematological Malignancies.International journal of molecular sciences · 2022
    Review
  8. Nrf2-siRNA Enhanced the Anti-Tumor Effects of AsJournal of hepatocellular carcinoma · 2022
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Re-sensitization of 5-FU resistance by SPARC through negative regulation of glucose metabolism in hepatocellular carcinoma.Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine · 2015
    Article
  14. Article
  15. Article
  16. Article
  17. A double-modulation strategy in cancer treatment with a chemotherapeutic agent and siRNA.Molecular therapy : the journal of the American Society of Gene Therapy · 2011
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

J F MirjoletCentre Alexis Vautrin, Laboratoire de Recherche en Oncologie, Avenue de Bourgogne, Vandoeuvre-les-Nancy cedex, 54511, USA.
M Barberi-Heyob
C Didelot
J P Peyrat
J Abecassis
R Millon
J L Merlin
Délégation Centre-Est · FRCentre Oscar Lambret · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

p53 tumour-suppressor gene is involved in cell growth control, arrest and apoptosis. Nevertheless cell cycle arrest and apoptosis induction can be observed in p53-defective cells after exposure to DNA-damaging agents such as 5-fluorouracil (5-FU) suggesting the importance of alternative pathways via p53-independent mechanisms. In order to establish relationship between p53 status, cell cycle arrest, Bcl-2/Bax regulation and 5-FU sensitivity, we examined p53 mRNA and protein expression and p53 protein functionality in wild-type (wt) and mutant (mt) p53 cell lines. p53 mRNA and p53 protein expression were determined before and after exposure to equitoxic 5-FU concentration in six human carcinoma cell lines differing in p53 status and displaying marked differences in 5-FU sensitivity, with IC(50)values ranging from 0.2-22.6 mM. 5-FU induced a rise in p53 mRNA expression in mt p53 cell lines and in human papilloma virus positive wt p53 cell line, whereas significant decrease in p53 mRNA expression was found in wt p53 cell line. Whatever p53 status, 5-FU altered p53 transcriptional and translational regulation leading to up-regulation of p53 protein. In relation with p53 functionality, but independently of p53 mutational status, after exposure to 5-FU equitoxic concentration, all cell lines were able to arrest in G1. No relationship was evidenced between G1 accumulation ability and 5-FU sensitivity. Moreover, after 5-FU exposure, Bax and Bcl-2 proteins regulation was under p53 protein control and a statistically significant relationship (r = 0.880, P = 0.0097) was observed between Bcl-2/Bax ratio and 5-FU sensitivity. In conclusion, whatever p53 status, Bcl-2 or Bax induction and Bcl-2/Bax protein ratio were correlated to 5-FU sensitivity.

Indexed as

AdenocarcinomaApoptosisbcl-2-Associated X ProteinBreast NeoplasmsCarcinomaCell CycleDose-Response Relationship, DrugFemaleFluorouracilGene Expression Regulation, NeoplasticGenes, p53Head and Neck NeoplasmsHumansPancreatic NeoplasmsProto-Oncogene ProteinsProto-Oncogene Proteins c-bcl-2BAX protein, humanbcl-2-Associated X ProteinFluorouracilProto-Oncogene ProteinsProto-Oncogene Proteins c-bcl-2RNA, Messenger

Identifiers

PMID11044365
PMCPMC2408783
OpenAlexW1498281658

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.